Manulife (Manufacturers Life Insurance)’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$894K Buy
76,734
+12,299
+19% +$143K ﹤0.01% 1875
2025
Q1
$479K Buy
64,435
+20,473
+47% +$152K ﹤0.01% 2167
2024
Q4
$264K Sell
43,962
-3,321
-7% -$19.9K ﹤0.01% 2509
2024
Q3
$242K Sell
47,283
-1,551
-3% -$7.94K ﹤0.01% 2578
2024
Q2
$177K Buy
48,834
+2,710
+6% +$9.81K ﹤0.01% 2651
2024
Q1
$148K Sell
46,124
-16,680
-27% -$53.5K ﹤0.01% 2685
2023
Q4
$308K Sell
62,804
-283
-0.4% -$1.39K ﹤0.01% 2398
2023
Q3
$344K Sell
63,087
-42,527
-40% -$232K ﹤0.01% 2308
2023
Q2
$709K Sell
105,614
-14,417
-12% -$96.7K ﹤0.01% 1837
2023
Q1
$1.06M Buy
120,031
+227
+0.2% +$2K ﹤0.01% 1610
2022
Q4
$910K Buy
119,804
+791
+0.7% +$6.01K ﹤0.01% 1657
2022
Q3
$828K Sell
119,013
-782
-0.7% -$5.44K ﹤0.01% 1690
2022
Q2
$979K Buy
119,795
+63,171
+112% +$516K ﹤0.01% 1661
2022
Q1
$785K Buy
+56,624
New +$785K ﹤0.01% 1896